Cargando…

Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model

BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse...

Descripción completa

Detalles Bibliográficos
Autores principales: Perinel, Sophie, Leclerc, Lara, Prévôt, Nathalie, Deville, Agathe, Cottier, Michèle, Durand, Marc, Vergnon, Jean-Michel, Pourchez, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937580/
https://www.ncbi.nlm.nih.gov/pubmed/27388488
http://dx.doi.org/10.1186/s12931-016-0395-7
_version_ 1782441732889116672
author Perinel, Sophie
Leclerc, Lara
Prévôt, Nathalie
Deville, Agathe
Cottier, Michèle
Durand, Marc
Vergnon, Jean-Michel
Pourchez, Jérémie
author_facet Perinel, Sophie
Leclerc, Lara
Prévôt, Nathalie
Deville, Agathe
Cottier, Michèle
Durand, Marc
Vergnon, Jean-Michel
Pourchez, Jérémie
author_sort Perinel, Sophie
collection PubMed
description BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse aerosols with different size ranges [0.15 μm–0.5 μm], [0.25 μm–1 μm] and [1 μm–9 μm]. SPECT/CT analyses were performed complementary in order to assess more precisely the regional deposition of aerosols within the pulmonary tract. Experiments were set using an original respiratory tract model composed of a human plastinated head connected to an ex vivo porcine pulmonary tract. The model was ventilated by passive expansion, simulating pleural depressions. Aerosol was administered during nasal breathing. RESULTS: Planar scintigraphies allowed to calculate the deposited aerosol fractions for particles in the three size ranges from sub-micron to micron The deposited fractions obtained, for thoracic vs. extra-thoracic regions respectively, were 89 ± 4 % vs. 11 ± 4 % for [0.15 μm–0.5 μm], 78 ± 5 % vs. 22 ± 5 % for [0.25 μm–1 μm] and 35 ± 11 % vs.65 ± 11 % for [1 μm–9 μm]. CONCLUSION: Results obtained with this new ex vivo respiratory tract model are in good agreement with the in vivo data obtained in studies with baboons and humans.
format Online
Article
Text
id pubmed-4937580
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49375802016-07-09 Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model Perinel, Sophie Leclerc, Lara Prévôt, Nathalie Deville, Agathe Cottier, Michèle Durand, Marc Vergnon, Jean-Michel Pourchez, Jérémie Respir Res Research BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse aerosols with different size ranges [0.15 μm–0.5 μm], [0.25 μm–1 μm] and [1 μm–9 μm]. SPECT/CT analyses were performed complementary in order to assess more precisely the regional deposition of aerosols within the pulmonary tract. Experiments were set using an original respiratory tract model composed of a human plastinated head connected to an ex vivo porcine pulmonary tract. The model was ventilated by passive expansion, simulating pleural depressions. Aerosol was administered during nasal breathing. RESULTS: Planar scintigraphies allowed to calculate the deposited aerosol fractions for particles in the three size ranges from sub-micron to micron The deposited fractions obtained, for thoracic vs. extra-thoracic regions respectively, were 89 ± 4 % vs. 11 ± 4 % for [0.15 μm–0.5 μm], 78 ± 5 % vs. 22 ± 5 % for [0.25 μm–1 μm] and 35 ± 11 % vs.65 ± 11 % for [1 μm–9 μm]. CONCLUSION: Results obtained with this new ex vivo respiratory tract model are in good agreement with the in vivo data obtained in studies with baboons and humans. BioMed Central 2016-07-07 2016 /pmc/articles/PMC4937580/ /pubmed/27388488 http://dx.doi.org/10.1186/s12931-016-0395-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Perinel, Sophie
Leclerc, Lara
Prévôt, Nathalie
Deville, Agathe
Cottier, Michèle
Durand, Marc
Vergnon, Jean-Michel
Pourchez, Jérémie
Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title_full Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title_fullStr Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title_full_unstemmed Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title_short Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
title_sort micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937580/
https://www.ncbi.nlm.nih.gov/pubmed/27388488
http://dx.doi.org/10.1186/s12931-016-0395-7
work_keys_str_mv AT perinelsophie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT leclerclara micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT prevotnathalie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT devilleagathe micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT cottiermichele micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT durandmarc micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT vergnonjeanmichel micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel
AT pourchezjeremie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel